Jessica Martin

Intranasal naloxone may have comparable efficacy and tolerability to intramuscular naloxone.

OnabotulinumtoxinA was shown to have a better outcome in patients with chronic migraine who start the treatment within 12 months of symptom onset.

Methadone exposure in utero was shown to increase the risk for neonatal abstinence syndrome compared with buprenorphine exposure.

Cooled radiofrequency ablation may provide greater pain relief compared with intraarticular steroid injection in patients with osteoarthritis-related chronic knee pain.

Peripheral nerve blocks may reduce postoperative pain and increase patient satisfaction in adults undergoing elective primary hip replacement.

Consensus statement cautions against the use of hormonal contraceptives in women with migraine, as these medications may be associated with an increased risk for ischemic stroke.

Peripheral nerve stimulation may provide long-term pain relief in patients with painful mononeuropathy
secondary to leprosy.

Intranasal administration of benzhydrocodone, a prodrug of hydrocodone, was shown to be associated with reduced hydrocodone exposures and decreased drug liking.

Surgical intervention with arthroscopic subacromial decompression may not yield a clinically significant reduction in shoulder pain and function in patients with subacromial pain.

The higher interictal levels of oxytocin observed in patients with chronic migraine compared with unaffected individuals may contribute to the affective component of experimental pain.